Abstract:e13517 Background: Clear cell renal cell carcinoma (ccRCC) represents the most common histological subtype of RCC, with poor response to chemotherapy and radiotherapy. Immunotherapy and novel therapies targeting angiogenesis signaling pathways have proved to be effective for RCC patients (pts). However, the comprehensive genomic features of ccRCC in Chinese pts have not been well understood. Methods: Deep sequencing targeting 450 cancer genes was performed on FFPE and matched blood samples collected from 39 Chinese ccRCC pts with a median age of 54 years (range 31-75) and a male-to-female ratio of 3.3. Genomic alterations (GAs) including single nucleotide variations, short and long insertions and deletions, copy number variations, and gene rearrangements were analyzed. Tumor mutation burden (TMB) and microsatellite instability (MSI) status were assessed by standard NGS algorithms. Results: In the Chinese cohort, the most common genomic alterations were detected in VHL (82.1%), PBRM1 (53.8%), SETD2 (20.5%), PTEN (15.4%), BAP1 (17.9%), TSC1/2 (15.4%), TP53 (10.3%), TERT (7.7%), MTOR (7.7%), KMT2C (7.7%), and CHD2 (7.7%). In total, 80% of the pts had one or more actionable GAs. The chromosome 3p tumor suppressors (VHL, PBRM1, and SETD2) were identified in 87% of the pts. PI3K/mTOR pathway alterations including PTEN, MTOR, TSC1/2 and PIK3CA mutations were detected in 30% of the pts. Compared with TCGA data (501 pts), we found higher mutation frequency of VHL, PBRM1, and PTEN in the current Chinese cohort. The median TMB value of our ccRCC pts was 5.6 muts/Mb (range: 0-58); 8.3% of the pts had TMB greater than or equal to 20 muts/Mb. Three ccRCC pts were identified as MSI-H. One pt with a novel MET fusion responded well to cabozantinib. Conclusions: Compared with the TCGA data set mostly based on Western population, our Chinese cohort revealed that the genomic alteration frequencies of chromosome 3p tumor suppressors (VHL, PBRM1, and SETD2) were higher compared with TCGA (VHL: 82.1% vs 49.3%; PBRM1: 53.8% vs 30.1%; SETD2: 20.5% vs 12.4%). The NGS-based comprehensive genomic profiling assay could detect all GAs, TMB, and MSI status simultaneously, and suggest personalized treatment options of targeted therapy and immunotherapy for ccRCC pts.

Additional File 3 of Characterization of Novel CTNNB1 Mutation in Craniopharyngioma by Whole-Genome Sequencing

Characterization of Novel CTNNB1 Mutation in Craniopharyngioma by Whole-Genome Sequencing.

A novel mutation in CRYBB2 responsible for inherited coronary cataract

Additional File 4: of Identification and Characterization of NF1 and Non-Nf1 Congenital Pseudarthrosis of the Tibia Based on Germline NF1 Variants: Genetic and Clinical Analysis of 75 Patients

Identification of a novel splice mutation in CTNNB1 gene in a Chinese family with both severe intellectual disability and serious visual defects

Additional File 4: of Molecular and Clinical Characterization of PTPN2 Expression from RNA-seq Data of 996 Brain Gliomas

Additional File 2: of Novel Compound Heterozygous Mutations in CNGA1in a Chinese Family Affected with Autosomal Recessive Retinitis Pigmentosa by Targeted Sequencing

Additional File 7: of Molecular and Clinical Characterization of PTPN2 Expression from RNA-seq Data of 996 Brain Gliomas

Additional File 2 of Characterizing Sensitivity and Coverage of Clinical WGS As a Diagnostic Test for Genetic Disorders

Whole‐exome sequencing has revealed novel genetic characteristics in intracranial germ cell tumours in the Chinese

Mutation of CTNBB1 gene in human craniopharyngioma tissues and its meanings

Comprehensive Genomic Profiling in Chinese Patients with Clear Cell Renal Cell Carcinoma.

Transcriptomic Characterization of Hepatocellular Carcinoma with CTNNB1 Mutation

Whole-exome Sequencing to Identify Novel Mutations of Nevoid Basal Cell Carcinoma Syndrome in a Chinese Population

Additional File 5: of Identification and Characterization of NF1 and Non-Nf1 Congenital Pseudarthrosis of the Tibia Based on Germline NF1 Variants: Genetic and Clinical Analysis of 75 Patients

Clinical characteristics and identification of novel CNOT1 variants in three unrelated Chinese families with Vissers-Bodmer Syndrome

P1.03-28 Association Between Molecular Characteristics of CTNNB1 Mutations and Prognosis in Patients with Nsclc in Chinese Patients

Additional File 2: of Whole Exome Sequencing Identified a Novel Truncation Mutation in the NHS Gene Associated with Nance-Horan Syndrome

[Identification of a Novel Inheritable CCM1 Gene Mutation of 671del AT in a Chinese Family with Cerebral Cavernous Malformation].

Additional File 1 of Diagnostic Yield and Novel Candidate Genes for Neurodevelopmental Disorders by Exome Sequencing in an Unselected Cohort with Microcephaly

High Copy-Number Variation Burdens in Cranial Meningiomas From Patients With Diverse Clinical Phenotypes Characterized by Hot Genomic Structure Changes